Human Gene Therapy for Retinal Disorders: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 28, 2020
April 11, 2024
3bca1550-9cef-41e0-b826-9a48c8984afa
Related Documents
Human Gene Therapy for Rare Diseases: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Human Gene Therapy for Neurodegenerative Diseases: Guidance for Industry
Guidance DocumentOctober 21, 2022Center for Biologics Evaluation and Research
Human Gene Therapy for Hemophilia: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.